 Evans GW,
Palmer MK, et al. Measuring Effects on intima media Thickness: an
Evaluation Of Rosuvastatin in subclinical atherosclerosisâ€“the rationale
and methodology of the METEOR study.. Cardiovasc Drugs Ther
2004;18:231-8.

JOURNAL OF VASCULAR SURGERY
Volume 54, Number 3

121. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis
MN. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol: a randomized trial comparing
the effects of atorvastatin and pravastatin on carotid intima medial
thickness. Circulation 2002;106:2055-60.
122. Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJ,
Stalenhoef AF. Effect of aggressive versus conventional lipid lowering
on atherosclerosis progression in familial hypercholesterolemia
(ASAP): a prospective, randomised, double-blind trial. Lancet 2001;
357:577-81.
123. National Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel III). Third Report of the National
Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood cholesterol in Adults (Adult
Treatment Panel III) final report. Circulation 2002;106:3143-421.
124. van den Bogaard B, van den Born BJ, Fayyad R, Waters DD, DeMicco
DA, LaRosa JC, et al. On-treatment lipoprotein components and risk
of cerebrovascular events in the Treating to New Targets study. Eur
J Clin Invest 2011;41:134-42.
125. Avellone G, Di Garbo V, Guarnotta V, Scaglione R, Parrinello G,
Purpura L, et al. Efficacy and safety of long